SBTX

Skinbiotherapeutics (SBTX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:SBTX
DataOraFonteTitoloSimboloCompagnia
11/04/202412:44RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
05/04/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice & Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
22/03/202412:34Alliance NewsAlliance NewsSkinBioTherapeutics half-year revenue jumps on UK-based salesLSE:SBTXSkinbiotherapeutics Plc
22/03/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Half-year ReportLSE:SBTXSkinbiotherapeutics Plc
18/03/202415:17Alliance NewsAlliance NewsSkinBioTherapeutics announces research into wound healing bacteriumLSE:SBTXSkinbiotherapeutics Plc
18/03/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC New research project and CSO to return to academiaLSE:SBTXSkinbiotherapeutics Plc
12/03/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
08/03/202410:43RNS Regulatory NewsSkinBioTherapeutics PLC Notice of ResultsLSE:SBTXSkinbiotherapeutics Plc
28/02/202421:31Alliance NewsAlliance NewsTRADING UPDATES: Avacta plans fundraise to fund clinical developmentLSE:SBTXSkinbiotherapeutics Plc
28/02/202413:41RNS Regulatory NewsSkinBioTherapeutics PLC Conversion notice and alternative financingLSE:SBTXSkinbiotherapeutics Plc
27/02/202418:42Alliance NewsAlliance NewsTRADING UPDATES: Windward extends LSEG pact; Vinanz eyes DTC tradingLSE:SBTXSkinbiotherapeutics Plc
27/02/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Positive Interim AxisBiotix Acne study resultsLSE:SBTXSkinbiotherapeutics Plc
20/02/202414:52Alliance NewsAlliance NewsSkinBio's Dermatonics launches Once Heel Balm in Asia, ME and AfricaLSE:SBTXSkinbiotherapeutics Plc
20/02/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Dermatonics to launch Once Heel Balm in AMEALSE:SBTXSkinbiotherapeutics Plc
06/02/202415:29Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics up after successful year for DermatonicsLSE:SBTXSkinbiotherapeutics Plc
06/02/202408:31RNS Regulatory NewsSkinBioTherapeutics PLC Dermatonics Full Year trading updateLSE:SBTXSkinbiotherapeutics Plc
26/01/202411:36Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics completes Dermatonics purchaseLSE:SBTXSkinbiotherapeutics Plc
26/01/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Completion of Acquisition of DermatonicsLSE:SBTXSkinbiotherapeutics Plc
25/01/202415:57Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics buys Dermatonics; in talks for 2nd dealLSE:SBTXSkinbiotherapeutics Plc
25/01/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC Acquisition of DermatonicsLSE:SBTXSkinbiotherapeutics Plc
25/01/202408:00RNS Regulatory NewsSkinBioTherapeutics PLC £5.0m Convertible Bond Facility & First DrawdownLSE:SBTXSkinbiotherapeutics Plc
29/12/202314:29Alliance NewsAlliance NewsSkinBioTherapeutics suffers acquisition delay but aims for early 2024LSE:SBTXSkinbiotherapeutics Plc
29/12/202311:49UK RegulatorySkinBioTherapeutics PLC Result of AGMLSE:SBTXSkinbiotherapeutics Plc
29/12/202309:13UK RegulatorySkinBioTherapeutics PLC Update on transaction timelines to early 2024LSE:SBTXSkinbiotherapeutics Plc
06/12/202308:00UK RegulatorySkinBioTherapeutics PLC Notice of AGM and posting of Annual ReportLSE:SBTXSkinbiotherapeutics Plc
30/11/202322:10Alliance NewsAlliance NewsEARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widenLSE:SBTXSkinbiotherapeutics Plc
30/11/202318:25UK RegulatorySkinBioTherapeutics PLC Final ResultsLSE:SBTXSkinbiotherapeutics Plc
30/11/202315:25Alliance NewsAlliance NewsTRADING UPDATES: SkinBio launches food supplement on AmazonLSE:SBTXSkinbiotherapeutics Plc
30/11/202308:00UK RegulatorySkinBioTherapeutics PLC AxisBiotix-Ps(TM) to launch on Amazon UKLSE:SBTXSkinbiotherapeutics Plc
22/11/202308:00UK RegulatorySkinBioTherapeutics PLC Update regarding Nominated Adviser and BrokerLSE:SBTXSkinbiotherapeutics Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:SBTX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network